Fortive (FTV) shares have retreated over the past month and past 3 months, with returns of 8.9% and 4.0% respectively. This has prompted some investors to reassess the company’s fundamentals and recent financial profile.
The group generates revenue of about US$4.16b and net income of roughly US$532.7m. Its operations are split between its Intelligent Operating Solutions and Advanced Healthcare Solutions segments across the United States, Asia Pacific, Europe, Latin America, and other regions.
See our latest analysis for Fortive.
At a share price of US$53.92, Fortive has seen weaker short term momentum, with a 1 month share price return of 8.9% and a year to date share price return of 2.7%. The 3 year total shareholder return of 6.4% points to more modest longer term gains and suggests sentiment has cooled recently.
If you are comparing Fortive with other companies exposed to automation, sensors, and industrial software, this is a good moment to broaden your search and review 32 robotics and automation stocks
So with Fortive trading at about US$53.92 after a period of weaker returns, is the current valuation still conservative given its earnings profile, or is the market already reflecting much of its future growth potential in the price?
Fortive's most followed narrative values the shares at $72.00, comfortably above the last close of $53.92, and frames the current price as a discount on expected earnings quality and cash generation.
The company's clear leadership in digital transformation and connected workflow solutions, evidenced by strong momentum in cloud-based products, AI-enabled customer retention, and market-leading SaaS innovation, directly positions Fortive to capture outsized share of the long-term surge in industrial automation and digitalization, creating a powerful, compounding runway for revenue and EBITDA growth.
Curious how a company with modest revenue growth expectations can still warrant a higher fair value and richer future earnings multiple? The key assumptions around margins, recurring software revenue, and what investors are willing to pay for those profits tell an interesting story. Want to see how those moving parts combine into a single number and how sensitive that fair value is to small shifts in earnings power?
Result: Fair Value of $72.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, if supply chain pressures increase and Fortive’s reliance on cyclical industrial and healthcare spending faces renewed headwinds, the upbeat margin and valuation narrative could quickly be challenged.
Find out about the key risks to this Fortive narrative.
If this mix of risks and rewards leaves you unsure, now is a good time to test the numbers yourself and pressure check the narrative. To weigh both sides in one place, review the 3 key rewards and 1 important warning sign
If Fortive has sharpened your focus, now is the moment to widen your watchlist with fresh, data backed ideas you might regret overlooking later.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English